{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T10:59:05Z","timestamp":1771844345159,"version":"3.50.1"},"reference-count":137,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Reviews in Medical Virology"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Designing and manufacturing efficient vaccines against coronavirus disease 2019 (COVID\u201019) is a major objective. In this systematic review, we aimed to evaluate the most important vaccines under construction worldwide, their efficiencies and clinical results in healthy individuals and in those with specific underlying diseases. We conducted a comprehensive search in PubMed, Scopus, EMBASE, and Web of Sciences by 1 December 2021 to identify published research studies. The inclusion criteria were publications that evaluated the immune responses and safety of COVID\u201019 vaccines in healthy individuals and in those with pre\u2010existing diseases. We also searched the VAERS database to estimate the incidence of adverse events of special interest (AESI) post COVID\u201019 vaccination. Almost all investigated vaccines were well tolerated and developed good levels of both humoural and cellular responses. A protective and efficient humoural immune response develops after the second or third dose of vaccine and a longer interval (about 28\u00a0days) between the first and second injections of vaccine could induce higher antibody responses. The vaccines were less immunogenic in immunocompromised patients, particularly those with haematological malignancies. In addition, we found that venous and arterial thrombotic events, Bell's palsy, and myocarditis\/pericarditis were the most common AESI. The results showed the potency of the SARS\u2010CoV\u20102 vaccines to protect subjects against disease. The provision of further effective and safe vaccines is necessary in order to reach a high coverage of immunisation programs across the globe and to provide protection against infection itself.<\/jats:p>","DOI":"10.1002\/rmv.2359","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T05:29:28Z","timestamp":1651469368000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Recent developments in SARS\u2010CoV\u20102 vaccines: A systematic review of the current studies"],"prefix":"10.1002","volume":"33","author":[{"given":"Mona","family":"Sadeghalvad","sequence":"first","affiliation":[{"name":"Department of Immunology School of Medicine Tehran University of Medical Sciences  Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir Hossein","family":"Mansourabadi","sequence":"additional","affiliation":[{"name":"Department of Immunology School of Medicine Tehran University of Medical Sciences  Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Noori","sequence":"additional","affiliation":[{"name":"Student Research Committee, School of Medicine Iran University of Medical Sciences  Tehran Iran"},{"name":"Urology Research Center Tehran University of Medical Sciences  Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8692-9720","authenticated-orcid":false,"given":"Seyed Aria","family":"Nejadghaderi","sequence":"additional","affiliation":[{"name":"Systematic Review and Meta\u2010Analysis Expert Group (SRMEG) Universal Scientific Education and Research Network (USERN)  Tehran Iran"},{"name":"School of Medicine Shahid Beheshti University of Medical Sciences  Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoomeh","family":"Masoomikarimi","sequence":"additional","affiliation":[{"name":"Department of Immunology School of Medicine Tehran University of Medical Sciences  Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoumeh","family":"Alimohammadi","sequence":"additional","affiliation":[{"name":"Department of Immunology School of Medicine Tehran University of Medical Sciences  Tehran Iran"},{"name":"Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA) Universal Scientific Education and Research Network (USERN)  Tehran Iran"},{"name":"Research Center for Immunodeficiencies Children's Medical Center Tehran University of Medical Sciences  Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3836-1827","authenticated-orcid":false,"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[{"name":"Department of Immunology School of Medicine Tehran University of Medical Sciences  Tehran Iran"},{"name":"Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA) Universal Scientific Education and Research Network (USERN)  Tehran Iran"},{"name":"Research Center for Immunodeficiencies Children's Medical Center Tehran University of Medical Sciences  Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,5]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118185"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41564\u2010020\u20100695\u2010z"},{"issue":"4","key":"e_1_2_11_4_1","article-title":"Strategies for vaccine development of COVID\u201019","volume":"36","author":"Yang L","year":"2020","journal-title":"Chin J Biotechnol"},{"key":"e_1_2_11_5_1","unstructured":"OrganizationWH.World health organization (WHO) coronavirus disease (COVID\u201019). Dashboard 2021.https:\/\/covid19.who.int\/"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577\u2010020\u201000434\u20106"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.7326\/m20\u20101632"},{"key":"e_1_2_11_8_1","volume-title":"Inactivated Viral Vaccines, p 45\u201380. Vaccine Analysis: Strategies, Principles, and Control","author":"Sanders B","year":"2014"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.243"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines2030624"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7201752"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2017.08.014"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.00862"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines5010006"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1516552"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454\u2010200404000\u201000002"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.07.035"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.8565"},{"key":"e_1_2_11_20_1","article-title":"Randomized, double\u2010blinded and placebo\u2010controlled phase II trial of an inactivated SARS\u2010CoV\u20102 vaccine in healthy adults","author":"Che Y","year":"2020","journal-title":"Clin Infect Dis"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02000-6"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1473\u20103099(21)00070\u20100"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1473\u20103099(20)30942\u20107"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.09.052"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2107715"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000001573"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.04.006"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140\u20106736(21)01429\u2010x"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1473\u20103099(20)30987\u20107"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.15543"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1473\u20103099(20)30831\u20108"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1473\u20103099(20)30843\u20104"},{"key":"e_1_2_11_33_1","doi-asserted-by":"crossref","unstructured":"Zhang Y\u2010J Zeng G Pan H\u2010X et\u00a0al.Immunogenicity and safety of a SARS\u2010CoV\u20102 inactivated vaccine in healthy adults aged 18\u201059 years: report of the randomized double\u2010blind and placebo\u2010controlled phase 2 clinical trial. medRxiv. 2020:2020.07.31.20161216.","DOI":"10.1101\/2020.07.31.20161216"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2028436"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00508\u2010021\u201001922\u2010y"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591\u2010021\u201001330\u20109"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2027906"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2022483"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586\u2010020\u20102814\u20107"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586\u2010020\u20102639\u20104"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.02.007"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2034577"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2110345"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2035389"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2113017"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2107456"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.3645"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140\u20106736(20)31208\u20103"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-01179-4"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1473\u20103099(21)00147\u2010x"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140\u20106736(20)31866\u20103"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102214"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392\u2010021\u201000692\u20103"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2034201"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31604-4"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140\u20106736(20)31605\u20106"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140\u20106736(21)00628\u20100"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32466-1"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32661-1"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25982-w"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140\u20106736(21)00234\u20108"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2101544"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1473\u20103099(21)00200\u20100"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003769"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2107659"},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2026920"},{"key":"e_1_2_11_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140\u20106736(21)00241\u20105"},{"key":"e_1_2_11_68_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2103055"},{"key":"e_1_2_11_69_1","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000001702"},{"key":"e_1_2_11_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1473\u20103099(21)00127\u20104"},{"key":"e_1_2_11_71_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2021.1951126"},{"key":"e_1_2_11_72_1","doi-asserted-by":"crossref","unstructured":"Ward BJ Gobeil P S\u00e9guin A et\u00a0al.Phase 1 trial of a candidate recombinant virus\u2010like particle vaccine for Covid\u201019 disease produced in plants. medRxiv. 2020:2020.11.04.20226282.","DOI":"10.1101\/2020.11.04.20226282"},{"key":"e_1_2_11_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2352\u20103026(21)00169\u20101"},{"key":"e_1_2_11_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.05.036"},{"key":"e_1_2_11_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.06.009"},{"key":"e_1_2_11_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.06.014"},{"key":"e_1_2_11_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17568"},{"key":"e_1_2_11_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375\u2010021\u201001300\u20107"},{"key":"e_1_2_11_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470\u20102045(21)00155\u20108"},{"key":"e_1_2_11_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.06.002"},{"key":"e_1_2_11_81_1","doi-asserted-by":"crossref","unstructured":"Agha M Blake M Chilleo C Wells A Haidar G.Suboptimal response to COVID\u201019 mRNA vaccines in hematologic malignancies patients. medRxiv: the preprint server for health sciences. 2021:2021.04.06.21254949","DOI":"10.1101\/2021.04.06.21254949"},{"key":"e_1_2_11_82_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00392\u2010021\u201001880\u20105"},{"key":"e_1_2_11_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.242"},{"key":"e_1_2_11_84_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9070708"},{"key":"e_1_2_11_85_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16713"},{"key":"e_1_2_11_86_1","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2021040490"},{"key":"e_1_2_11_87_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16702"},{"key":"e_1_2_11_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13654"},{"key":"e_1_2_11_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2021.05.004"},{"key":"e_1_2_11_90_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2199"},{"key":"e_1_2_11_91_1","doi-asserted-by":"publisher","DOI":"10.3390\/v13050756"},{"key":"e_1_2_11_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.04.020"},{"key":"e_1_2_11_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470\u20102045(21)00213\u20108"},{"key":"e_1_2_11_94_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9040360"},{"key":"e_1_2_11_95_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.06.002"},{"key":"e_1_2_11_96_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab193"},{"key":"e_1_2_11_97_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40620\u2010021\u201001076\u20100"},{"key":"e_1_2_11_98_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab179"},{"key":"e_1_2_11_99_1","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.03500321"},{"key":"e_1_2_11_100_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.704773"},{"key":"e_1_2_11_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2665\u20109913(21)00186\u20107"},{"key":"e_1_2_11_102_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis\u20102021\u2010220503"},{"key":"e_1_2_11_103_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis\u20102021\u2010220272"},{"key":"e_1_2_11_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.05.029"},{"key":"e_1_2_11_105_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis\u20102021\u2010220597"},{"key":"e_1_2_11_106_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.7563"},{"key":"e_1_2_11_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.05.041"},{"key":"e_1_2_11_108_1","volume-title":"Statistics and Research\/Coronavirus (COVID\u201019) Vaccinations 2021","author":"OWi Data"},{"key":"e_1_2_11_109_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577\u2010020\u201000480\u20100"},{"key":"e_1_2_11_110_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.1c01451"},{"key":"e_1_2_11_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.01.015"},{"key":"e_1_2_11_112_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586\u2010022\u201004465\u2010y"},{"key":"e_1_2_11_113_1","article-title":"Increased risk of SARS\u2010CoV\u20102 reinfection associated with emergence of the Omicron variant in South Africa","author":"Pulliam JR","year":"2021","journal-title":"MedRxiv"},{"key":"e_1_2_11_114_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmc2119270"},{"key":"e_1_2_11_115_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abn7591"},{"key":"e_1_2_11_116_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591\u2010020\u20100771\u20101"},{"key":"e_1_2_11_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.02.001"},{"key":"e_1_2_11_118_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25726"},{"key":"e_1_2_11_119_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00831\u201020"},{"key":"e_1_2_11_120_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0401939101"},{"key":"e_1_2_11_121_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature02463"},{"key":"e_1_2_11_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.03.007"},{"key":"e_1_2_11_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100040"},{"key":"e_1_2_11_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.04.023"},{"key":"e_1_2_11_125_1","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11517"},{"key":"e_1_2_11_126_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-45024-6_2"},{"key":"e_1_2_11_127_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2014"},{"key":"e_1_2_11_128_1","doi-asserted-by":"publisher","DOI":"10.3201\/1107.050219"},{"key":"e_1_2_11_129_1","article-title":"Safety and immunogenicity of an inactivated SARS\u2010CoV\u20102 vaccine, BBIBP\u2010CorV: a randomised, double\u2010blind, placebo\u2010controlled, phase 1\/2 trial","author":"Xia S","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"e_1_2_11_130_1","article-title":"Development of an inactivated vaccine candidate for SARS\u2010CoV\u20102","author":"Gao Q","journal-title":"Science"},{"key":"e_1_2_11_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.06.008"},{"key":"e_1_2_11_132_1","article-title":"A Newcastle disease virus (NDV) expressing membrane\u2010anchored spike as a cost\u2010effective inactivated SARS\u2010CoV\u20102 vaccine","author":"Sun W","year":"2020","journal-title":"bioRxiv"},{"key":"e_1_2_11_133_1","doi-asserted-by":"publisher","DOI":"10.7774\/cevr.2012.1.1.35"},{"key":"e_1_2_11_134_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8040584"},{"key":"e_1_2_11_135_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202008319"},{"key":"e_1_2_11_136_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2024671"},{"key":"e_1_2_11_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.07.019"},{"key":"e_1_2_11_138_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591\u2010021\u201001370\u20101"}],"container-title":["Reviews in Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rmv.2359","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/rmv.2359","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rmv.2359","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T16:50:55Z","timestamp":1706892655000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/rmv.2359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":137,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1002\/rmv.2359"],"URL":"https:\/\/doi.org\/10.1002\/rmv.2359","archive":["Portico"],"relation":{},"ISSN":["1052-9276","1099-1654"],"issn-type":[{"value":"1052-9276","type":"print"},{"value":"1099-1654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"2022-01-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2359"}}